Kidney Cancer Coverage from Every Angle
Editor:
Robert J. Motzer, MD
Advertisement
Advertisement

Ongoing CE Activities

Active Surveillance Safe for Small Renal Tumors
ARCHIVED MONTHLY ONCOLOGY TUMOR BOARDS: A MULTIDISCIPLINARY APPROACH TO INDIVIDUALIZED PATIENT CARE - KIDNEY CANCER
Atezolizumab-Bevacizumab Misses Survival Endpoint in Metastatic RCC
BCOP Test-Advances in Targeted Therapy and Immunotherapy For The Treatment of Kidney Cancer
Cabozantinib Active Across Rarer, Heterogeneous, Non-Clear Cell RCCs
Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Genitourinary Cancers
Cancer Summaries and Commentaries™: Report From Chicago on Advances in Genitourinary Cancers
Community Practice Connections™: 3rd Annual School of Nursing Oncology™
Community Practice Connections™: Leveraging Evolving Data Sets to Inform Treatment Decision-Making in Advanced RCC: An Expert Tumor Board Discussion
Community Practice Connections®: Medical Crossfire®: Crossroads in Advanced RCC Decision- Making: With Many Options, How Will You Treat Your Patient Today?... And Tomorrow?
Community Practice Connections™: Nursing Essentials: Optimized Care Strategies for the Patient With Advanced Renal Cell Carcinoma
Community Practice Connections™: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting
Expert Insights on Emerging Data for the Use of Immunotherapy in Advanced RCC [login required]
IL-10 Agonist Paired With Anti-PD-1 Shows Promise in Lung, Kidney Cancer
NCCN Guidelines Updates: Management of Metastatic Kidney Cancer
NCCN Guidelines® Insights – Kidney Cancer, Version 2.2020
NCCN Pharmacy Updates: Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer
NCCN Pharmacy Updates: Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer
PD-1 Inhibitor Disappoints in mRCC With Untreated Brain Metastases
Proceedings from the First Annual Oncology Nursing Retreat: Renal Cell Carcinoma
RECORDED PRESENTATION FROM THE NCCN PHARMACY UPDATES: ADVANCES IN TARGETED THERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF KIDNEY CANCER
Renal Cell Carcinoma (RCC): Optimizing Pharmacotherapeutic and Interventional Management Strategies
Updates in the Role of Immune Checkpoint Inhibitors for the Management of RCC [login required]
Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.